Posts by Admin BioAlps

HUG | Preventive treatment for people in contact with COVID-19 patients   The HUG launch a clinical trial called CoPEP to validate a preventive treatment for patients which have been in contact with COVID-19 infected patients. The trial will be divided in three parts. The first two parts of the trial will test the efficiency…

Avenue de Sécheron, 15

EBAMed joins the Mayo Clinic Business Accelerator and starts pre-clinical testing   EBAMed SA, a medical technology company enabling access to non-invasive treatments for heart arrhythmias, is glad to announce its entry into the Mayo Clinic Business Accelerator located in Rochester, Minnesota, USA, in January 2020. This will allow EBAMed, which develops medical devices to…

Los Angeles – Geneva – Monthey: CSG-BIO SA (CSG-Bio), which intends to offer the most advanced and comprehensive stem cell banking services to families worldwide in the near future, took over some of CryoSave AG’s assets in 2019. It has now announced the signing of an agreement with CORDSAVINGS SA (CordSavings), the reputed independent Swiss neonatal stem cells laboratory, to secure the hundreds of thousands of stem cell samples left in insecurity following the bankruptcy of the Swiss company Cryo-Save AG in September 2019.

New appointment at SOPHiA GENETICS to accelerate the execution of its Medical Strategy   On 13 February 2020, SOPHiA GENETICS, leader in Data-Driven Medicine, announced the appointment of Philippe Menu, MD-PhD, MBA, as Chief Medical Officer. The arrival of Dr. Philippe Menu in the SOPHiA GENETICS team will enable the Swiss based company to expand its…

Lunaphore closes its Series C funding   On 6 February 2020, the EPFL spin-off, Lunaphore, founded in 2014, announced the completion of its Series C funding of CHF 23 million, adding to its existing capital of CHF 11.3 million.   The startup provides high speed qualitative automated tools which use immunohistochemistry to deliver precise diagnostics. Lunaphore…

New centre of excellence in the canton of Vaud | GE Healthcare Life Sciences   GE Healthcare Life Sciences will build a new manufacturing site in the Signy Park in Gens, in the canton of Vaud, by 2022.   The 7’360 square meter facility will support the US-based multinational to meet increasing global demand for…

Creation of a European Consortium | ORGANTRANS   On 4 February 2020, the CSEM announced the creation of  the European project ORGANTRANS. The project will be financed by the H2020 programme and coordinated by the CSEM. The eight partners taking part in the project aim to develop a disruptive solution able to create organ structure through 3D tissue…

The Swiss Venture Capital Report 2020 is out | Encouraging results for biotech and healthcare IT sectors   The 8th edition of the Swiss Venture Capital Report (SVCR), published by startupticker.ch and the investor association SECA, depicts changes in the Swiss innovation landscape.   After a decrease in investment in Swiss biotech startups in 2018,…

European Innovation Council (EIC) Accelerator | Novostia part of the 9 selected Swiss startups   The European Commission selected 75 startups and SMEs out of 1852 applicants from the European Union to take part in the EIC Accelerator pilot. Novostia, the Neuchâtel-based medtech startup, was selected among the Swiss projects.   €278 million will be allocated to…